UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils: possible role in invasion through basement membranes

The Journal of clinical investigation, 1985-10, Vol.76 (4), p.1306-1313

1985

Volltextzugriff (PDF)

Subcellular localization of heparanase in human neutrophils

Journal of leukocyte biology, 1992-06, Vol.51 (6), p.519-524

1992

Volltextzugriff (PDF)

Inhibition of Heparanase-Mediated Degradation of Extracellular Matrix Heparan Sulfate by Non-anticoagulant Heparin Species

Blood, 1987-08, Vol.70 (2), p.551-557

1987

Volltextzugriff (PDF)

Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: relationship to tumor cell metastasis

Cancer research (Chicago, Ill.), 1983-06, Vol.43 (6), p.2704-2711

1983

Volltextzugriff (PDF)

Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species

Blood, 1987-08, Vol.70 (2), p.551-557

1987

Volltextzugriff (PDF)

Sequential degradation of heparan sulfate in the subendothelial extracellular matrix by highly metastatic lymphoma cells

International journal of cancer, 1985-04, Vol.35 (4), p.483-491

1985

Volltextzugriff (PDF)

Heparan sulfate degradation in tumor cell invasion and angiogenesis

Advances in experimental medicine and biology, 1988, Vol.233, p.201

1988

Volltextzugriff (PDF)

Phenylbutyrate Induces Cell Differentiation and Modulates Epstein-Barr Virus Gene Expression in Burkitt’s Lymphoma Cells

Clinical cancer research, 1999-06, Vol.5 (6), p.1509-1516

1999

Volltextzugriff (PDF)

Role of Heparanase in Platelet and Tumor Cell Interactions with the Subendothelial Extracellular Matrix

Seminars in thrombosis and hemostasis, 1987-10, Vol.13 (4), p.475-488

1987

Volltextzugriff (PDF)

Involvement of both heparanase and plasminogen activator in lymphoma cell-mediated degradation of heparan sulfate in the subendothelial extracellular matrix

Journal of cellular physiology, 1986-08, Vol.128 (2), p.299-306

1986

Volltextzugriff (PDF)

Transfected wild-type and mutant max regulate cell growth and differentiation of murine erythroleukemia cells

Oncogene, 1993-05, Vol.8 (5), p.1263-1268

1993

Volltextzugriff (PDF)

Regulation of murine max (Myn) parallels the regulation of c-Myc in differentiating murine erythroleukemia cells

Cell growth & differentiation, 1994-08, Vol.5 (8), p.847-854

1994

Volltextzugriff (PDF)

Regions within the c-Myc protein that are necessary for transformation are also required for inhibition of differentiation of murine erythroleukemia cells

Cell growth & differentiation, 1992-03, Vol.3 (3), p.183-190

1992

Volltextzugriff (PDF)

Involvement of heparanase in tumor metastasis and angiogenesis

Israel journal of medical sciences, 1988-09, Vol.24 (9-10), p.464

1988

Volltextzugriff (PDF)

Inhibition of Murine Erythroleukemia Cell Differentiation by Normal and Partially Deleted c-myc Genes

Immunobiology (1979), 1992-08, Vol.185 (2), p.150-158

1992

Volltextzugriff (PDF)

Involvement of both heparanase and plaminogen activator in lymphoma cell-mediated degradation of heparan sulfate in the subendothelial extracellular matrix

Journal of cellular physiology, 1986, Vol.128 (2), p.299-306

1986

Volltextzugriff (PDF)

A T-LYMPHOMA DERIVED PROTEINASE, SYNERGIZING WITH AN ENDOGLYCOSIDASE IN THE DEGRADATION OF SULPHATED PROTEOGLYCANS IN SUBENDOTHELIAL EXTRACELLULAR MATRIX

Proteinases in Inflammation and Tumor Invasion, 1986, p.373-394

1986

Volltextzugriff (PDF)

A novel multipotent sigma 1/M1 muscarinic activator for a comprehensive therapeutic strategy in Alzheimer's disease

Neurobiology of aging, 2014-03, Vol.35, p.S6-S7

2014

Volltextzugriff (PDF)

AF150(S) and AF267B: M1 muscarinic agonists as innovative therapies for Alzheimer's disease

Journal of molecular neuroscience, 2002-08, Vol.19 (1-2), p.145-153

2002

Volltextzugriff (PDF)

Thiol Mediated Free Radical Cyclization of Alkenyl and Alkynyl Isocyanides

Journal of organic chemistry, 1994-12, Vol.59 (25), p.7752-7758

1994

Volltextzugriff (PDF)

AF710B, a Novel M1/σ1 Agonist with Therapeutic Efficacy in Animal Models of Alzheimer's Disease

Neuro-degenerative diseases, 2016-01, Vol.16 (1-2), p.95-110

2016

Volltextzugriff (PDF)

Synthesis of alkynyl(phenyl)iodonium triflates and their reaction with diethyl 2-aminomalonate

Journal of organic chemistry, 1991-06, Vol.56 (12), p.3912-3915

1991

Volltextzugriff (PDF)

Impact of muscarinic agonists for successful therapy of Alzheimer's disease

Journal of neural transmission. Supplementum, 2002 (62), p.189

2002

Volltextzugriff (PDF)

Synthesis of highly functionalized β-lactams. Alkynylation of 2-oxoazetidin-1-yl malonates

Journal of organic chemistry, 1993-12, Vol.58 (27), p.7923-7924

1993

Volltextzugriff (PDF)

AF710B, a Novel M1/[sigma]1 Agonist with Therapeutic Efficacy in Animal Models of Alzheimer's Disease

Neuro-degenerative diseases, 2016-02, Vol.16 (1-2), p.95

2016

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(33)
Buchkapitel
(1)

Sprache

Englisch
(33)
Deutsch
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils: possible role in invasion through basement membranes

Subcellular localization of heparanase in human neutrophils

Inhibition of Heparanase-Mediated Degradation of Extracellular Matrix Heparan Sulfate by Non-anticoagulant Heparin Species

Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: relationship to tumor cell metastasis

Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species

Sequential degradation of heparan sulfate in the subendothelial extracellular matrix by highly metastatic lymphoma cells

Heparan sulfate degradation in tumor cell invasion and angiogenesis

Phenylbutyrate Induces Cell Differentiation and Modulates Epstein-Barr Virus Gene Expression in Burkitt’s Lymphoma Cells

Role of Heparanase in Platelet and Tumor Cell Interactions with the Subendothelial Extracellular Matrix

Involvement of both heparanase and plasminogen activator in lymphoma cell-mediated degradation of heparan sulfate in the subendothelial extracellular matrix

Transfected wild-type and mutant max regulate cell growth and differentiation of murine erythroleukemia cells

Regulation of murine max (Myn) parallels the regulation of c-Myc in differentiating murine erythroleukemia cells

Regions within the c-Myc protein that are necessary for transformation are also required for inhibition of differentiation of murine erythroleukemia cells

Involvement of heparanase in tumor metastasis and angiogenesis

Inhibition of Murine Erythroleukemia Cell Differentiation by Normal and Partially Deleted c-myc Genes

Involvement of both heparanase and plaminogen activator in lymphoma cell-mediated degradation of heparan sulfate in the subendothelial extracellular matrix

A T-LYMPHOMA DERIVED PROTEINASE, SYNERGIZING WITH AN ENDOGLYCOSIDASE IN THE DEGRADATION OF SULPHATED PROTEOGLYCANS IN SUBENDOTHELIAL EXTRACELLULAR MATRIX

A novel multipotent sigma 1/M1 muscarinic activator for a comprehensive therapeutic strategy in Alzheimer's disease

AF150(S) and AF267B: M1 muscarinic agonists as innovative therapies for Alzheimer's disease

Thiol Mediated Free Radical Cyclization of Alkenyl and Alkynyl Isocyanides

AF710B, a Novel M1/σ1 Agonist with Therapeutic Efficacy in Animal Models of Alzheimer's Disease

Synthesis of alkynyl(phenyl)iodonium triflates and their reaction with diethyl 2-aminomalonate

Impact of muscarinic agonists for successful therapy of Alzheimer's disease

Synthesis of highly functionalized β-lactams. Alkynylation of 2-oxoazetidin-1-yl malonates

AF710B, a Novel M1/[sigma]1 Agonist with Therapeutic Efficacy in Animal Models of Alzheimer's Disease

Suchergebnisse filtern